Patent Grant
9723842
Isothiazolinones, such as 1,2-benzisothiazolin-3-one ( also referred to as “BIT”), are know to be effective antimicrobials. BIT, as disclosed for example in formulations described in European patent EP 0 703 726, is widely used as a bactericide in a variety of applications. Illustratively, British patent publication GB2,230,190A discloses a preservative composition containing BIT and an adduct of zinc chloride (“ZC”), together with 2,2′-dithiopyridine-1,1′-dioxide (“DTP”). Example 3 of '190A publication compares compositions containing BIT plus ZC plus DTP against a control example containing only BIT plus ZC. The results given in Example 3 and Table 3 of the publication indicate that inclusion of DTP allows decreased usage of BIT in the composition. Nonetheless, the amount of BIT (2.5 ppm) employed in the control example has been found by the present inventors to be insufficient for antimicrobial efficacy in real-world applications.
While BIT has proven useful in a wide range of applications, the useful amount of BIT that can be added to a commercial product is limited by efficacy and economic considerations and to a lesser extent by environmental and toxicological concerns. Accordingly, alternative antimicrobial compositions are needed for wet state applications that are cost-effective and minimize the likelihood of adverse environmental and toxicological effects. The present invention provides one such alternative.
In one aspect, the present invention relates to an antimicrobial composition comprising (a) at least one isothiazolin-3-one and (b) at least one zinc compound selected from the group consisting of zinc salts, zinc oxides, zinc hydroxides, and combinations thereof. Illustrative zinc salts are zinc chloride, zinc sulfide, zinc carbonate, basic zinc carbonate, and combinations thereof. The zinc compound provides a source of metal ion in the antimicrobial composition. In the composition, the isothiazolin-3-one is present in an amount of from 1 to 500 ppm (preferably from 5 to 500 ppm), the zinc compound is present in an amount from 5 to 200,000 ppm (preferably from 5 to 500 ppm), and the weight ratio of the isothiazolin-3-one to the zinc compound is from 1:2000 to 100:1 (preferably from 1:100 to 100:1). Optionally, the antimicrobial composition additionally comprises a pyrithione salt or pyrithione acid. Useful pyrithione salts include copper pyrithione, zinc pyrithione, sodium pyrithione, pyrithione disulfide, and combinations thereof.
In another aspect, the present invention relates to an antimicrobial composition concentrate that, upon dilution with water, provides antimicrobial efficacy in a functional fluid. The concentrate comprises (a) at least one isothiazolin-3-one and (b) at least one zinc compound selected from the group consisting of zinc salts, zinc oxides, zinc hydroxides, and combinations thereof. In the concentrate, component (a) is present in an amount of from 1 to 95% w/w, and component (b) is present in an amount of from 1 to 50% w/w based on the total weight of the concentrate, with the proviso that the weight percent of (a) plus (b) does not exceed 100% by weight.
In yet another aspect, the present invention relates to functional fluid that comprises a base medium plus (a) at least one isothiazolin-3-one and (b) at least one zinc compound selected from the group consisting of zinc salts, zinc oxides, zinc hydroxides, and combinations thereof. Illustrative zinc salts are zinc chloride, zinc sulfide, zinc carbonate, basic zinc carbonate, and combinations thereof. In the composition, the isothiazolin-3-one is present in an amount of from 1 to 500 ppm (preferably from 5 to 500 ppm), the metal compound is present in an amount of from 5 to 200,00 ppm (preferably from 5 to 500 ppm), and the weight ratio of the isothiazolin-3-one to zinc ion is from 1:2000 to 100:1 (preferably from 100:1 to 1:100). Optionally, the antimicrobial composition additionally comprises a pyrithione salt or pyrithione acid. Useful pyrithione salts include copper pyrithione, zinc pyrithione, sodium pyrithione, and pyrithione disulfide. The base medium for the functional fluid can be, for example, a polymer useful in polymer emulsions. Examples of polymer systems are lattices, such as acrylic and substituted (meth)acrylates, styrene/butadiene, ethylene vinyl acetate, polyvinyl acetate, styrene/butadiene/N-methylol acrylamide, nitrile and copolymers of the aforementioned. Typical functional fluids include coating compositions, such as paints, adhesives, sealants, caulks, mineral and pigment slurries, printing inks, agricultural pesticide formulations, household products, personal care, metal working fluids and other aqueous based systems.
These and other aspects will become apparent upon reading the following detailed description of the invention.
It has now been surprisingly found in accordance with the present invention that an antimicrobial composition containing an isothiazolin-3-one, plus a zinc compound selected from the group consisting of zinc salts, zinc oxides, zinc hydroxides, and combinations thereof, exhibits enhanced antimicrobial efficacy, as compared to isothiazolin-containing compositions that do not contain the metal compound. Enhanced efficacy are suitably provided in antimicrobial compositions over a wide range of pHs of from 3 to 12.
The antimicrobial composition of the present invention is suitably incorporated into a functional fluid. The functional fluid suitably comprises a base medium plus (a) at least one isothiazolin-3-one and (b) at least one zinc compound selected from the group consisting of zinc salts of organic acids, zinc salts of inorganic acids, zinc oxides, zinc hydroxides, and combinations thereof. Illustrative zinc salts include zinc chloride, zinc sulfide, zinc carbonate, basic zinc carbonate (also known as “hydroxy-containing zinc carbonate”, also know as “zinc hydroxy carbonate” which is further identified by the empirical formula Zn5(OH)6(CO3)2), and combinations thereof.
The isothiazolinone useful in the present invention is preferably an isothiazolin-3-one that is selected from: 1,2-benzisothiazolin-3-one (“BIT”), N-(n-butyl)-1,2-benzisothiazolin-3-one (“BBIT”), 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (“DCOIT”), 2-methyl-4-isothiazolin-3-one (“MIT”), mixtures of 5-chloro-2-methyl-4-isothiazolin-3-one (“CIMIT”) plus MIT (available from Rohm and Haas Company, Philadelphia, Pa. under the tradename Kathon®) dithio-2,2′-bis(benzmethylamide), and combinations thereof. Particularly preferred isothiazolins are BIT, MIT and BBIT, and combinations thereof.
In the composition, the isothiazolin-3-one is present in an amount of from 1 to 500 ppm (preferably from 5 to 500 ppm), the zinc compound is present in an amount of from 5 to 200,000 ppm (preferably from 5 to 500 ppm), and the weight ratio of the isothiazolin-3-one to the zinc compound is from 1:2000 to 100:1 (preferably from 100:1 to 1:100).
Optionally, the antimicrobial composition additionally comprises a pyrithione salt or pyrithione acid. Useful pyrithione salts include copper pyrithione, zinc pyrithione, sodium pyrithione. If used, the pyrithione salt or pyrithione acid is suitably present in the composition in an amount of from about 0.001% w/w to about 1.0% w/w.
In one embodiment, the combination of antimicrobial components for the antimicrobial composition can be provided in the form of an antimicrobial composition concentrate that, upon dilution with water, provides antimicrobial efficacy in a functional fluid. The concentrate comprises (a) at least one isothiazolin-3-one and (b) at least one zinc compound selected from the group consisting of zinc salts, zinc oxides, zinc hydroxides, and combinations thereof. In the concentrate, component (a) is present in an amount of from 1 to 95% w/w, and component (b) is present in an amount of from 1 to 50% w/w.
The antimicrobial compositions of the present invention are suitably used in functional fluids such as polymer emulsions, or other coating compositions, to impart both wet state and dry film preservation. The base medium can be, for example, a polymer useful in polymer emulsions wherein the polymer is selected from the group consisting of acrylic and substituted (meth)acrylates, styrene/butadiene, ethylene vinyl acetate, polyvinyl acetate, styrene/butadiene/N-methylol acrylamide, nitrile and copolymers of the aforementioned. Typical functional fluids include coating compositions, such as paints, adhesives, sealants, caulks, mineral and pigment slurries, printing inks, agricultural pesticide formulations, household products, personal care, metal working fluids and other aqueous based systems.
The invention is further described in the Examples given below. All percentages given herein are weight percents based on the total weight of the composition, unless otherwise stated. All patents referred to in this application are incorporated herein by reference in their entirety.
In this example, samples of a commercial water based acrylic latex, trade name REVACRYL 1A, supplied by the Harlow Chemical Company, pH 8.1, containing antimicrobial additives in amounts as identified in Table I below, were challenged with a bacterial suspension consisting of
All test species were cultured onto nutrient agar and incubated for 24 hours at 30° C. After this period individual suspensions of each test organism were prepared at a concentration of 106 colony forming units per ml in saline solution by means of a Thoma counting chamber, achieved by mixing equal volumes of the individual suspensions. The concentration of bacteria in each aliquot after each challenge was 2×106 per ml.
The antimicrobial additive-containing paint samples were stored at 40° C. for 7 days prior to commencing the test. The paint samples were challenged with 1% v/v of bacterial suspension as described above. All test samples were incubated at 30° C. for the duration of the test and examined for viable bacteria after 1, 3 and 7 days after each challenge. Viable bacteria were detected by streaking aliquots onto nutrient agar followed by incubation at 30° C. for 2 days.
Table I presents the results obtained after the third inoculation days 1, 3 and 7.
Results demonstrate a potentiating effect on BIT in combination with a zinc containing salt when compared against a commercial product, namely PROXEL BD20 a product of Arch Chemicals, Inc. containing only a BIT for the preservation of a commercial latex in that only 100 ppm of BIT is required in the presence of a zince containing salt compared to 250 ppm of BIT for sample containing only BIT.
Investigation of Potentiation Between 1,2-Benzisothiazolin-3-one (BIT) and Zinc Chloride (ZnCl2) Against Pseudomonas aeruginosa.
Bacteria
Pseudomonas aeruginosa (NCIB 10421) maintained on nutrient agar, were used to study the synergy between BIT and ZnCl2.
Calculation of Minimum Inhibitory Concentrations Against Mono-cultures
Bacteria were grown to stationary phase (approximately 24 hours) in nutrient broth (approximately 109 organisms per ml). A 0.1% (v/v) inoculum was used to seed fresh medium and 100 μl of the inoculum was then added to each well of a microtitre plate, except for the first well which contained 200 μl.
Using doubling dilutions, the concentration of the compounds under investigation were varied in each well along the ordinate axis. The presence or absence of growth was recorded by visual inspection after 24 hours incubation at 37° C.
Calculation of Antimicrobial Activity Against Mono-cultures
Microtitre plates were used for this assay. A simple matrix was constructed with varied concentrations of the two compounds from 2×MIC (minimum inhibitory concentration) down to zero concentration in a 10×10 array. As the microtitre plate has only 96 wells, the combinations of the two compounds that made up the extreme concentrations (highest and lowest) were omitted. Solutions were made up in broth at two times the final concentrations after pre-dissolving the compounds in distilled water.
The mixture (100 μl) was added to the plate so that the total volume in each well was 200 μl. Nutrient broth was used for Ps. aeruginosa. Plates were incubated for 16-24 hours at 37°. The presence or absence of growth was determined by visual inspection.
Results for Example 2
Table 2: Antimicrobial Activity of Compounds Under Investigation
Ps. aeruginosa
Calculation of activity Against Mono-cultures
The Minimum Inhibitory Concentration (MIC) is the lowest concentration of biocide which showed growth inhibition when used alone. For the purpose of Fractional Inhibitory Concentration (FIC) calculations, if a single biocide did not control growth, the MIC was taken as the highest concentration used. A Fractional Inhibitory Concentration is the concentration of biocide which controlled growth in the mixture divided by the MIC of that biocide. FIC values for both compounds in the mixture were calculated and the results are shown in Table 3. The sum of these two figures gives an indication of the action of the two biocides. A value less than one indicates an enhanced effect, if the total is unity or greater the action is additive and if the value is greater than two the biocides are antagonistic.
Table 3: Fractional Inhibitory Concentrations for 1,2-Benzisothiazolin-3-one (BIT) and Zinc Chloride (ZnCl2) against Ps. aeruginosa
If a graph with the axes representing the biocide Fractional Inhibitory Concentrations for the two biocides on linear scales is constructed, when the combination is additive the isobole ( i.e. the line joining the points that represent all combinations with the same effect including the equally effective concentrations of the biocides used alone) is straight, enhanced combinations give concave isoboles and antagonistic combinations give convex isoboles. As shown in
Investigation of potentiation between Kathon® (CIMIT/MIT) and Zinc Chloride (ZnCl2) against Pseudomonas aeruginosa.
Bacteria
Pseudomonas aeruginosa (NCIB 10421) maintained on nutrient agar, were used to study the synergy of Kathon® and ZnCl2.
Calculation of Minimum Inhibitory Concentrations Against Mono-cultures
Bacteria were grown to stationary phase (approximately 24 hours) in nutrient broth (approximately 109 organisms per ml). A 0.1% (v/v) inoculum was used to seed fresh medium and 100 μl of the inoculum was then added to each well of a microtitre plate, except for the first well which contained 200 μl.
Using doubling dilutions, the concentration of the compounds under investigation were varied in each well along the ordinate axis. The presence or absence of growth was recorded by visual inspection after 24 hours incubation at 37° C.
Calculation of Antimicrobial Activity Against Mono-cultures
Microtitre plates were used for this assay. A simple matrix was constructed with varied concentrations of the two compounds from 2×MIC (minimum inhibitory concentration) down to zero concentration in a 10×10 array. As the microtitre plate has only 96 wells, the combinations of the two compounds that made up the extreme concentrations (highest and lowest) were omitted. Solutions were made up in broth at two times the final concentrations after pre-dissolving the compounds in distilled water.
The mixture (100 μl) was added to the plate so that the total volume in each well was 200 μl. Nutrient broth was used for Ps. aeruginosa. Plates were incubated for 16-24 hours at 37°. The presence or absence of growth was determined by visual inspection.
Results of Example 3
Table 4: Antimicrobial Activity of Compounds Under Investigation
The mixture of CIMIT and MIT is available from Rohm and Haas Company, Philadelphia, Pa. under the tradename Kathon®.
Calculation of Synergy Against Mono-cultures
The Minimum Inhibitory Concentration (MIC) is the lowest concentration of biocide which showed growth inhibition when used alone. For the purpose of Fractional Inhibitory Concentration (FIC) calculations, if a single biocide did not control growth, the MIC was taken as the highest concentration used. A Fractional Inhibitory Concentration is the concentration of biocide which controlled growth in the mixture divided by the MIC of that biocide. FIC values for both compounds in the mixture were calculated and the results are shown in Table 5. The sum of these two figures gives an indication of the action of the two biocides. A value less than one indicates an enhanced effect, if the total is unity or greater the action is additive and if the value is greater than two the biocides are antagonistic.
Table 5: Fractional Inhibitory Concentrations for Kathon (CIMIT/MIT) and Zinc Chloride (ZnCl2) against Ps. aeruginosa
If a graph with the axes representing the biocide Fractional Inhibitory Concentrations for the two biocides on linear scales is constructed, when the combination is additive the isobole (i.e. the line joining the points that represent all combinations with the same effect including the equally effective concentrations of the biocides used alone) is straight, enhanced combinations give concave isoboles and antagonistic combinations give convex isoboles. As shown in
Investigation of potentiation between MIT and Zinc Chloride (ZnCl2) against Pseudomonas aeruginosa
Bacteria
Pseudomonas aeruginosa (NCIB 10421) maintained on nutrient agar, were used to study the synergy between MIT and ZnCl2.
Calculation of Minimum Inhibitory Concentrations Against Mono-cultures
Bacteria were grown to stationary phase (approximately 24 hours) in nutrient broth (approximately 109 organisms per ml). A 0.1% (v/v) inoculum was used to seed fresh medium and 100 μl of the inoculum was then added to each well of a microtitre plate, except for the first well which contained 200 μl.
Using doubling dilutions, the concentration of the compounds under investigation were varied in each well along the ordinate axis. The presence or absence of growth was recorded by visual inspection after 24 hours incubation at 37° C.
Calculation of Antimicrobial Activity Against Mono-cultures
Microtitre plates were used for this assay. A simple matrix was constructed with varied concentrations of the two compounds from 2×MIC (minimum inhibitory concentration) down to zero concentration in a 10×10 array. As the microtitre plate has only 96 wells, the combinations of the two compounds that made up the extreme concentrations (highest and lowest) were omitted. Solutions were made up in broth at two times the final concentrations after pre-dissolving the compounds in distilled water.
The mixture (100 μl) was added to the plate so that the total volume in each well was 200 μl. Nutrient broth was used for Ps. aeruginosa. Plates were incubated for 16-24 hours at 37°. The presence or absence of growth was determined by visual inspection.
Results of Example 4
Table 6: Antimicrobial Activity of Compounds Under Investigation
Calculation of Synergy Against Mono-cultures
The Minimum Inhibitory Concentration (MIC) is the lowest concentration of biocide which showed growth inhibition when used alone. For the purpose of Fractional Inhibitory Concentration (FIC) calculations, if a single biocide did not control growth, the MIC was taken as the highest concentration used. A Fractional Inhibitory Concentration is the concentration of biocide which controlled growth in the mixture divided by the MIC of that biocide. FIC values for both compounds in the mixture were calculated and the results are shown in Table 7. The sum of these two figures gives an indication of the action of the two biocides. A value less than one indicates an enhanced effect, if the total is unity or greater the action is additive and if the value is greater than two the biocides are antagonistic.
Table 7: Fractional Inhibitory Concentrations for (MIT) and Zinc Chloride (ZnCl2) against Ps. aeruginosa
If a graph with the axes representing the biocide Fractional Inhibitory Concentrations for the two biocides on linear scales is constructed, when the combination is additive the isobole (i.e. the line joining the points that represent all combinations with the same effect including the equally effective concentrations of the biocides used alone) is straight, enhanced combinations give concave isoboles and antagonistic combinations give convex isoboles. As shown in
Investigation of Potentiation between BBIT and Zinc Chloride (ZnCl2) against Pseudomonas aeruginosa.
Bacteria
Pseudomonas aeruginosa (NCIB 10421) maintained on nutrient agar, were used to study the synergy between BBIT and ZnCl2.
Calculation of Minimum Inhibitory Concentrations Against Mono-cultures
Bacteria were grown to stationary phase (approximately 24 hours) in nutrient broth (approximately 109 organisms per ml). A 0.1% (v/v) inoculum was used to seed fresh medium and 100 μl of the inoculum was then added to each well of a microtitre plate, except for the first well which contained 200 μl.
Using doubling dilutions, the concentration of the compounds under investigation were varied in each well along the ordinate axis. The presence or absence of growth was recorded by visual inspection after 24 hours incubation at 37° C.
Calculation of Antimicrobial Activity Against Mono-cultures
Microtitre plates were used for this assay. A simple matrix was constructed with varied concentrations of the two compounds from 2×MIC (minimum inhibitory concentration) down to zero concentration in a 10×10 array. As the microtitre plate has only 96 wells, the combinations of the two compounds that made up the extreme concentrations (highest and lowest) were omitted. Solutions were made up in broth at two times the final concentrations after pre-dissolving the compounds in distilled water.
The mixture (100 μl) was added to the plate so that the total volume in each well was 200 μl. Nutrient broth was used for Ps. aeruginosa. Plates were incubated for 16-24 hours at 37°. The presence or absence of growth was determined by visual inspection.
Results of Example 5
Table 8: Antimicrobial Activity of Compounds Under Investigation
Calculation of Synergy Against Mono-cultures
The Minimum Inhibitory Concentration (MIC) is the lowest concentration of biocide which showed growth inhibition when used alone. For the purpose of Fractional Inhibitory Concentration (FIC) calculations, if a single biocide did not control growth, the MIC was taken as the highest concentration used. A Fractional Inhibitory Concentration is the concentration of biocide which controlled growth in the mixture divided by the MIC of that biocide. FIC values for both compounds in the mixture were calculated and the results are shown in Table 9. The sum of these two figures gives an indication of the action of the two biocides. A value less than one indicates an enhanced effect, if the total is unity or greater the action is additive and if the value is greater than two the biocides are antagonistic.
Table 9: Fractional Inhibitory Concentrations for BBIT and Zinc Chloride (ZnCl2) against Ps. aeruginosa
If a graph with the axes representing the biocide Fractional Inhibitory Concentrations for the two biocides on linear scales is constructed, when the combination is additive the isobole (i.e. the line joining the points that represent all combinations with the same effect including the equally effective concentrations of the biocides used alone) is straight, enhanced combinations give concave isoboles and antagonistic combinations give convex isoboles. As shown in
Investigation of potentiation between 1,2-Benzisothiazolin-3-one (BIT) and Sodium Chloride (NaCl2) against Pseudomonas aeruginosa as compared to the Synergy between 1,2-Benzisothiazolin-3-one (BIT) and Zinc Chloride (ZnCl2) against Pseudomonas aeruginosa (Example 2)
Bacteria
Pseudomonas aeruginosa (NCIB 10421) maintained on nutrient agar, were used to study the efficacy of the combination of BIT with sodium chloride.
Calculation of Minimum Inhibitory Concentrations Against Mono-cultures
Bacteria were grown to stationary phase (approximately 24 hours) in nutrient broth (approximately 109 organisms per ml). A 0.1% (v/v) inoculum was used to seed fresh medium and 100 μl of the inoculum was then added to each well of a microtitre plate, except for the first well which contained 200 μl.
Using doubling dilutions, the concentration of the compounds under investigation were varied in each well along the ordinate axis. The presence or absence of growth was recorded by visual inspection after 24 hours incubation at 37° C.
Calculation of Antimicrobial Activity Against Mono-cultures
Microtitre plates were used for this assay. A simple matrix was constructed with varied concentrations of the two compounds from 2×MIC (minimum inhibitory concentration) down to zero concentration in a 10×10 array. As the microtitre plate has only 96 wells, the combinations of the two compounds that made up the extreme concentrations (highest and lowest) were omitted. Solutions were made up in broth at two times the final concentrations after pre-dissolving the compounds in distilled water.
The mixture (100 μl) was added to the plate so that the total volume in each well was 200 μl. Nutrient broth was used for Ps. aeruginosa. Plates were incubated for 16-24 hours at 37° . The presence or absence of growth was determined by visual inspection.
Results of Comparative Example A
Table 10: Antimicrobial Activity of Compounds Under Investigation
Calculation of Potentiation Against Mono-Cultures
The Minimum Inhibitory Concentration (MIC) is the lowest concentration of biocide which showed growth inhibition when used alone. For the purpose of Fractional Inhibitory Concentration (FIC) calculations, if a single biocide did not control growth, the MIC was taken as the highest concentration used. A Fractional Inhibitory Concentration is the concentration of biocide which controlled growth in the mixture divided by the MIC of that biocide. FIC values for both compounds in the mixture were calculated and the results are shown in Table 11. The sum of these two figures gives an indication of the action of the two biocides. A value less than one indicates an enhanced effect, if the total is unity or greater the action is additive and if the value is greater than two the biocides are antagonistic.
Table 11: Fractional Inhibitory Concentrations for 1,2-Benzisothiazolin-3-one (BIT) and Sodium Chloride (NaCl2) against Ps. aeruginosa
If a graph with the axes representing the biocide Fractional Inhibitory Concentrations for the two biocides on linear scales is constructed, when the combination is additive the isobole ( i.e. the line joining the points that represent all combinations with the same effect including the equally effective concentrations of the biocides used alone) is straight, enhanced combinations give concave isoboles and antagonistic combinations give convex isoboles. As shown in
This application claims the benefit of U.S. Provisional Application No. 60/808,697, filed May 26, 2006, the disclosure of which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3403119 | McCarthy et al. | Sep 1968 | A |
| 3976501 | Blue | Aug 1976 | A |
| 4031055 | Dupont et al. | Jun 1977 | A |
| 4150026 | Miller et al. | Apr 1979 | A |
| 4241214 | Miller et al. | Dec 1980 | A |
| 4299749 | McCarthy et al. | Nov 1981 | A |
| 5059456 | Larson et al. | Oct 1991 | A |
| 5125967 | Morpeth et al. | Jun 1992 | A |
| 5208272 | LeSota | May 1993 | A |
| 5221530 | Janchitraponvej et al. | Jun 1993 | A |
| 5227156 | Wiese | Jul 1993 | A |
| 5290810 | Austin | Mar 1994 | A |
| 5696083 | Nelson, Jr. | Dec 1997 | A |
| 5723112 | Bowser et al. | Mar 1998 | A |
| 5840790 | Ong | Nov 1998 | A |
| 5883154 | Kappock et al. | Mar 1999 | A |
| 6133300 | Smith et al. | Oct 2000 | A |
| 6156108 | Wachowiak, Jr. | Dec 2000 | A |
| 6433056 | Burdick et al. | Aug 2002 | B1 |
| 6455558 | Bath et al. | Sep 2002 | B1 |
| 7025952 | Traynor et al. | Apr 2006 | B1 |
| 20030071075 | Frankenbach | Apr 2003 | A1 |
| 20040014736 | El A'mma et al. | Jan 2004 | A1 |
| 20040014799 | Antoni-Zimmermann et al. | Jan 2004 | A1 |
| 20040198713 | Heer et al. | Oct 2004 | A1 |
| 20050065232 | Okimoto et al. | Mar 2005 | A1 |
| 20050101487 | Beilfuss | May 2005 | A1 |
| 20050197366 | Chia et al. | Sep 2005 | A1 |
| 20060009553 | Sin | Jan 2006 | A1 |
| 20060111410 | Wachtler et al. | May 2006 | A1 |
| 20070275945 | Lindner | Nov 2007 | A1 |
| Number | Date | Country |
|---|---|---|
| 0249328 | Dec 1987 | EP |
| 0425143 | May 1991 | EP |
| 0455379 | Nov 1991 | EP |
| 0492811 | Jul 1992 | EP |
| 1527685 | May 2005 | EP |
| 2200846 | Aug 1988 | GB |
| 2230190 | Oct 1990 | GB |
| S62-070301 | Mar 1987 | JP |
| H04-273852 | Sep 1992 | JP |
| H08-231317 | Sep 1996 | JP |
| H09-301805 | Nov 1997 | JP |
| 2003-055116 | Feb 2003 | JP |
| 2004-051635 | Feb 2004 | JP |
| 2005-281305 | Oct 2005 | JP |
| 9201380 | Feb 1992 | WO |
| WO 9403146 | Feb 1994 | WO |
| 9500019 | May 1995 | WO |
| 9622023 | Jul 1996 | WO |
| WO 9836904 | Aug 1998 | WO |
| 9965315 | Dec 1999 | WO |
| WO 0038520 | Jul 2000 | WO |
| WO 2004014416 | Feb 2004 | WO |
| WO 2004099308 | Nov 2004 | WO |
| WO 2007139645 | Dec 2007 | WO |
| Entry |
|---|
| Bulmer et al., “The antifungal action of dandruff shampoos”, 1999, Mycophathologia, vol. 147, pp. 63-65. |
| Simpson et al., Long term protection with fungicide and algicide development, PPCJ (1996). |
| Mattei et al., Formulating Stable Latex Paints With Zinc Oxide, Presented at the 68th Annual Meeting of the Federation of Societies for Coatings Technology in Washington, DC (1991). |
| Database WPI Section Ch, Week 8224, Derwent Publication Ltd., London, GB; Class C01, AN 82-94133E, XP002114948 & JP57156405A (Yoshitomi Pharm Ind KK), Sep. 27, 1982 (Sep. 27, 1982) abstract. |
| Third Party Observations for EP 07809194.9, Dated Feb. 27, 2015. |
| Proxel® BZ Preservative Technical Sheet, EPA Accepted Date of Apr. 22, 1999. |
| Proxel® BZ Preservative Technical Sheet, EPA Accepted Date of Feb. 27, 2002. |
| Examination Report of EP07809194.9, Dated Jan. 29, 2015. |
| Third Party Observations in EP07809194.9, Dated Dec. 3, 2014. |
| Third Party Observations for EP 07809194.9, Dated Jun. 8, 2016. |
| Third Party Observations for EP 07809194.9, Dated Jun. 23, 2016. |
| Number | Date | Country | |
|---|---|---|---|
| 20070275094 A1 | Nov 2007 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60808697 | May 2006 | US |
